|
Novartis Group News is an EIN News Service for health professionals. Constantly updated news and information about health.
Latest Novartis Group News
- Cattle conference is set for Monday 8 Nov 2009 02:15 GMT
... to Oklahoma Cooperative Extension Se-rvice, other meeting and meal sponsors are Stillwater Milling Co., Novartis Animal Health and Northwest Cattle-man's Association. Reser-vations should be made to Garfield County OSU ...
- Novartis Receives Regulatory Approval In Germany For Celtura®, A Cell Culture-based Influenza A(H1N1) Pandemic Vaccine 7 Nov 2009 09:49 GMT
... Novartis announced that it received approval from the German regulatory authorities for its adjuvanted cell ...
- MIT Enterprise Forum of Cambridge Presents "Vaccines and Global Health: New Technologies Create Glob 7 Nov 2009 16:51 GMT
... featuring all of the evening's presenters. Dr. Andrin Oswald, M.D., is CEO of the Novartis Vaccines and Diagnostics Division and a permanent attendee of Novartis' Executive Committee. Dr. Oswald ...
- New Pharmaceuticals research report from Business Insights 7 Nov 2009 19:34 GMT
... also captured a major share of the adult vaccines market. Wyeth's Prevnar 13vPnC and Novartis' Menveo are among the most promising vaccines in the industry pipeline. GSK's Cervarix is ...
- Hamilton Thorne files second quarter results as part of qualifying transaction requirements 7 Nov 2009 00:13 GMT
... such as Harvard University, MIT, Yale, DuPont, Monsanto, Charles River Labs, Jackson Labs, Merck, Novartis, Pfizer, Oxford University and Cambridge. >> Certain information in this press release may contain ...
- Drug Brings Wake-Up Call in Depression and OSA 7 Nov 2009 00:14 GMT
... Pharmaceuticals, Bristol-Myers Squibb, Jazz Pharmaceuticals, Johnson & Johnson Pharmaceutical Research & Development, King Pharmaceuticals, Novartis Pharmaceuticals Corporation, Roche, the Sleep Medicine Education Institute, Concert, Ovation, and Vanda. Two of ...
- WHO rejects homeopath concern on flu jab 7 Nov 2009 00:58 GMT
... said pregnant women shouldn't take either of the two vaccines licensed in Switzerland - Novartis' Focetria and GlaxoSmithKline's Pandemrix - claiming the effects on mothers and their unborn children ...
- CDC says US making progress on swine flu vaccine 7 Nov 2009 06:18 GMT
... seasonal and H1N1 vaccine from five makers -- GlaxoSmithKline Plc, AstraZeneca Plc's MedImmune unit, Novartis, Sanofi-Aventis, and CSL Limited. Robert Blendon of the Harvard School of Public Health and ...
- Indacaterol Produces Effective Bronchodilation in Patients With COPD During 1 Year of Treatment: Presented at CHEST 2009 7 Nov 2009 07:55 GMT
... 150-mcg, 300-mcg, and the placebo group, respectively. Funding for this study was provided by Novartis. [Presentation title: Once-Daily Indacaterol Provides Effective Bronchodilation Over 1 Year of Treatment in Patients ...
- New Options for Treatment of RA and Lupus are Focus of Rheumatology Thought Leader Panel 7 Nov 2009 19:18 GMT
... Centocor/Schering-Plough, Cytopia, Genentech/Roche, Genentech/Roche/Chugai, GlaxoSmithKline/Genmab, GSK/Human Genome Sciences, Incyte, Lexicon, Lilly, Merck, Merck Serono/ZymoGenetics, Novartis, Pharmacyclics, Rigel, UCB, UCB/Immunomedics, Pfizer/Trubion. This report can be purchased by contacting MedPredict. About ...
- Novartis receives regulatory approval in Germany for Celtura(R), a cell culture-based Influenza A(H1N1) pandemic vaccine 5 Nov 2009 06:42 GMT
... Novartis receives regulatory approval in Germany for Celtura(R), a cell culture-based Influenza A(H1N1) pandemic vaccine ...
- Novartis receives regulatory approval in Germany for Celturaî, a cell culture-based Influenza A(H1N1) pandemic vaccine 5 Nov 2009 11:55 GMT
... with protection against influenza in individuals from 3 to 50 years of age * Novartis continues to pursue registration of Celtura in other major countries Basel, November 5, 2009 ...
- Novartis announces USD 1 billion investment to build largest pharmaceutical R&D institute in China 3 Nov 2009 07:14 GMT
... AS. The issuer is solely responsible for the content of this announcement. -------------- * Novartis Institute of BioMedical Research in Shanghai, an integral part of the Novartis global R&D ...
- Novartis receives regulatory approval in Germany for Celtura®, a cell culture-based Influenza A(H1N1) pandemic vaccine 5 Nov 2009 06:34 GMT
... with protection against influenza in individuals from 3 to 50 years of age * Novartis continues to pursue registration of Celtura in other major countries Basel, November 5, 2009 ...
- Novartis receives regulatory approval in Germany for Celtura, a cell culture-based Influenza A(H1N1) pandemic vaccine 5 Nov 2009 14:18 GMT
... Novartis receives regulatory approval in Germany for Celtura, a cell culture-based Influenza A(H1N1) pandemic vaccine ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Healthcare Industry Today
|
a digital news provider
bbc.co.uk:
healthday.com:
reuters.com: